Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2368228
Max Phase: Preclinical
Molecular Formula: C62H100O15Si
Molecular Weight: 1113.55
Molecule Type: Unknown
Associated Items:
ID: ALA2368228
Max Phase: Preclinical
Molecular Formula: C62H100O15Si
Molecular Weight: 1113.55
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H]([C@@H](C)CC)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@H]2OC)C[C@H]1OC
Standard InChI: InChI=1S/C62H100O15Si/c1-17-19-20-21-22-26-50(63)72-56-42(8)69-52(33-48(56)66-13)74-57-43(9)70-51(34-49(57)67-14)73-53-38(4)24-23-25-44-36-68-58-55(77-78(15,16)60(10,11)12)41(7)31-47(62(44,58)65)59(64)71-46-32-45(28-27-39(53)5)75-61(35-46)30-29-40(6)54(76-61)37(3)18-2/h23-25,27,29-31,37-38,40,42-43,45-49,51-58,65H,17-22,26,28,32-36H2,1-16H3/b24-23+,39-27+,44-25+/t37-,38-,40-,42-,43-,45+,46-,47-,48+,49+,51-,52-,53-,54+,55+,56-,57-,58+,61+,62+/m0/s1
Standard InChI Key: BHKVPHICRVDRLX-RREVMLSNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1113.55 | Molecular Weight (Monoisotopic): 1112.6831 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Mrozik H, Eskola P, Fisher MH, Egerton JR, Cifelli S, Ostlind DA.. (1982) Avermectin acyl derivatives with anthelmintic activity., 25 (6): [PMID:7097720] [10.1021/jm00348a010] |
Source(1):